Finance

Senarai
IBAB:EBR
Ion Beam Applications SA
€15.86
+0.76%
(+0.12) 1H
12 Okt, 9:33:05 PG GMT+2  ·   EUR
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk IBAB...
Buka
€15.82
Tinggi
€15.86
Rendah
€15.70
Permodalan Pasaran
480.28J
Purata volum
17.73K
Volum
1.40K
Dividen
1.10%
Dividen suku tahunan
€0.04
Tarikh tanpa dividen
15 Jun 2026
Nisbah H/P
19.92
tgi 52 mgu
€17.76
rdh 52 mgu
€9.90
EPS
€0.80
Syer tertunggak
30.28J
Bilangan pekerja
2K
Buka
€15.82
Tinggi
€15.86
Rendah
€15.70
Permodalan Pasaran
480.28J
Purata volum
17.73K
Volum
1.40K
Dividen
1.10%
Dividen suku tahunan
€0.04
Tarikh tanpa dividen
15 Jun 2026
Nisbah H/P
19.92
tgi 52 mgu
€17.76
rdh 52 mgu
€9.90
EPS
€0.80
Syer tertunggak
30.28J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
IBA is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain and became a university spin-off. It employs about 1500 people in 40 locations. The company developed cyclotrons and integrated proton therapy centers is active in the field of proton therapy, dosimetry, radiopharmacy solutions and industrial sterilisation. IBA installed its first proton therapy equipment for Boston's Massachusetts General Hospital in 2001, and for University of Pennsylvania's Proton Center in 2009. It supplied equipment and services to Proton Partners International which was developing three proton beam therapy centers in the United Kingdom. In 2017, IBA invested €16 million in the construction of a new logistics and production center in Louvain-la-Neuve. Wikipedia
Perihal Ion Beam Applications SA
CEOOlivier Legrain
Pekerja2.26K
Diasaskan1986
Ibu pejabat-
Sektor-
Laporan sebelumnyaSemua nilai dalam EUR
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam EUR
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
157.64J
157.64J
161.87J
161.87J
Kos barangan yang dijual
102.83J
102.83J
107.40J
107.40J
Kos hasil
102.83J
102.83J
107.40J
107.40J
Perbelanjaan penyelidikan dan pembangunan
15.48J
15.48J
18.20J
18.20J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
30.94J
30.94J
28.22J
28.22J
Belanja kendalian
40.94J
40.94J
48.03J
48.03J
Jumlah belanja kendalian
143.77J
143.77J
155.43J
155.43J
Pendapatan kendalian
13.86J
13.86J
6.45J
6.45J
Pendapatan bukan kendalian lain
-1.29J
-1.29J
-
-
EBT termasuk item luar biasa
8.78J
8.78J
6.14J
6.14J
EBT tidak termasuk item luar biasa
13.05J
13.05J
6.20J
6.20J
Belanja cukai pendapatan
1.12J
1.12J
1.48J
1.48J
Kadar cukai berkesan
12.73%
12.73%
24.10%
24.10%
Belanja kendalian lain
-5.83J
-5.83J
1.60J
1.60J
Pendapatan bersih
7.67J
7.67J
4.66J
4.66J
Margin untung bersih
4.86%
4.86%
2.88%
2.88%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
2.13J
2.13J
1.88J
1.88J
Belanja faedah
-
-
-3.18J
-3.18J
Belanja faedah bersih
2.13J
2.13J
-1.31J
-1.31J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
15.80J
15.17J
8.41J
8.41J
Keuntungan atau kerugian daripada jualan aset
-
-
-
-
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google